Declaration of interests
NEGLECTED DISEASES
BS reports fees from the Drugs for Neglected Diseases initiative (DNDi) for the statistical report and consulting fees from CEMAG, D&A Pharma, Inventiva, and OT4B Pharma. WMK, SR, AP, OVM, NS-W, DNT, and AT report employment at the DNDi. SS declares that Swiss Tropical and Public Health Institute acted as a service provider for the DNDi by monitoring the study sites. All other authors declare no competing interests.